lucifer-yellow has been researched along with 5-nitro-2-(3-phenylpropylamino)benzoic-acid* in 2 studies
2 other study(ies) available for lucifer-yellow and 5-nitro-2-(3-phenylpropylamino)benzoic-acid
Article | Year |
---|---|
Role for electrical synapses in shaping the output of coupled peptidergic neurons from Lymnaea.
Electrically coupled neurons communicate through channel assemblies called gap junctions, which mediate the transfer of current from one cell to another. Electrical synapses ensure spike synchronization and reliable transmission, which influences bursting patterns and firing frequency. The present study concerns an electrically coupled two-neuron network in the gastropod mollusc, Lymnaea stagnalis. The neurons, designated Visceral Dorsal 1 (VD1) and Right Parietal Dorsal 2 (RPD2), are peptidergic, innervate aspects of the cardio-respiratory system, and show strong coupling, such that they fire synchronously. Using dual sharp-electrode current-clamp recording and morphological staining in isolated brain preparations, the hypothesis that the electrical synapse is necessary for accurate network output was tested. We found that both cells make extensive projections within and out of the brain, including across the visceral-parietal connective, which links VD1 and RPD2. Cutting this connective uncoupled the neurons and disrupted the firing rate and pattern of RPD2 more than VD1, consistent with VD1 being the master and RPD2 the follower. The electrical synapse was inhibited by select gap junction blockers, with niflumic acid and 5-nitro-2-(3-phenylpropylamino) benzoic acid decreasing the VD1→RPD2 and RPD2→VD1 coupling coefficients, whereas carbenoxolone, α-glycyrrhetinic acid, meclofenamic acid, and quinine were ineffective. There was little-to-no impact on VD1↔RPD2 firing synchrony or frequency when coupling was reduced pharmacologically. However, in the presence of gap junction blockers, suppressing the activity of VD1 by prolonged hyperpolarization revealed a distinct, low-frequency firing pattern in RPD2. This suggests that strong electrical coupling is key to maintaining a synchronous output and proper firing rate. Topics: Action Potentials; Animals; Brain; Carbenoxolone; Central Nervous System Agents; Electrical Synapses; Ganglia, Invertebrate; Glycyrrhetinic Acid; Isoquinolines; Lymnaea; Meclofenamic Acid; Neurons; Niflumic Acid; Nitrobenzoates; Patch-Clamp Techniques; Periodicity; Quinine | 2015 |
Pharmacological "cross-inhibition" of connexin hemichannels and swelling activated anion channels.
The study of ion channels has relied heavily on the use of pharmacological blocking agents. However, many of these agents have multiple effects, which may compromise interpretation of results when the affected mechanisms/pathways mediate similar functions. Volume regulated anion channels (VRAC) and connexin hemichannels can both mediate the release of glutamate and taurine, although these channels have distinct activation stimuli and hemichannels, but not VRAC, are permeable to Lucifer Yellow (LY). It has been reported that some anion channel blockers may inhibit connexin hemichannels. We further examined the effects of classic gap junction/hemichannel blockers and anion channel blockers on these channels. The typical VRAC blockers, NPPB, IAA-94, and tamoxifen blocked low divalent cation-induced glutamate and taurine release and LY loading, presumed due to hemichannel opening. The blocking action of these compounds on hemichannels was concentration dependent and fell within the same range where the drugs classically block VRACs. Conversely, carbenoxolone (CBX), the most widely used gap junction/hemichannel blocker, was an effective blocker of VRAC-mediated glutamate and taurine release, and blocked these channels at similar concentrations at which it blocked hemichannels. The CBX effect on VRACs was verified using astrocytes from connexin 43 knock out (Cx43 KO) animals. In these cells, the hypotonic induced amino acid flux was retained whereas the low divalent cation solution-induced flux was lost. These results extend our knowledge about "cross-inhibition" of VRACs and gap junctions/hemichannels by certain pharmacological agents. Given the overlap in function of these two types of channels, great care must be exerted in using pharmacological blockers to identify one channel from the other. Topics: Amino Acids; Analysis of Variance; Angiogenesis Inhibitors; Animals; Animals, Newborn; Astrocytes; Carbenoxolone; Cell Size; Cells, Cultured; Chromatography, High Pressure Liquid; Connexin 43; Glycyrrhetinic Acid; Hippocampus; Hypotonic Solutions; Indans; Ion Channel Gating; Ion Channels; Isoquinolines; Mice; Mice, Knockout; Nitrobenzoates; Rats; Tamoxifen | 2009 |